Reckitt Benckiser Sales Beat Estimates as Retailers Stock Up

  • Shares rise as much as 6.7%, steepest gain since October 2013
  • Company expects cold-remedy destocking in first half of 2016

Reckitt Benckiser Group Plc, the maker of Durex condoms and Nurofen painkillers, reported fourth-quarter sales growth that beat analyst estimates as retailers stocked up on cold remedies during a slow flu season.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.